SNBL USA
1
18M
1
0.02
1
- Areas of investment
Summary
In 1957 was created SNBL USA, which is appeared as Corporate Investor.
The top activity for fund was in 2015. The increased amount of exits for fund were in 2015. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The standard case for the fund is to invest in rounds with 2 partakers. The meaningful sponsors for the fund in investment in the same round are RA Capital Management. In the next rounds fund is usually obtained by Teva Pharmaceutical Industries, Redmile Group, RA Capital Management.
Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Wave Life Sciences. We can highlight the next thriving fund investment areas, such as Health Care, Medical Device.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.02
- Investments by industry
- Biotechnology (1)
- Health Care (1)
- Medical Device (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Wave Life Sciences | 02 Feb 2015 | Biotechnology, Health Care, Medical Device | Early Stage Venture | 18M | United States, Boston, Massachusetts |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.